Misoprostol Prior to Office Hysteroscopy in Patients With no Risk Factors for Experiencing Unacceptable Pain
Misoprostol Prior to Office Hysteroscopy in Patients With no Risk Factors for Experiencing Unacceptable Pain
The aim of this study is to assess whether vaginal misoprostol reduces pain during office
 hysteroscopy in parous patients with no risk factors for experiencing severe or unacceptable
 pain.
Cervical ripening with misoprostol to minimize the pain experienced during office
 hysteroscopy has been proposed by several authors.

 The use of misoprostol is usually associated with undesired side effects and therefore any
 beneficial effect of misoprostol on reducing pain should be weighed against its undesired
 side effects (nausea, vomiting, diarrhea, fever, shivering, pain) and coasts. Till now , no
 studies have yet determined whether misoprostol should be used routinely or for the subgroup
 of patients at higher risk for cervical stenosis.

 The aim of this study is to assess whether vaginal misoprostol reduces pain during office
 hysteroscopy in parous patients with no risk factors for experiencing severe or unacceptable
 pain.
Inclusion Criteria:

 -  Patients with at least one vaginal delivery who have an indication for office
 hysteroscopy.

 Exclusion Criteria:

 -  Nulliparous patients, menopausal patients and patients with cervical pathology, and
 previous history of caesarean section or cervical surgery